diazatri - CAS号查询

热门搜索化学品最多只显示前20条，请点击“搜索化学品”查看所有结果

CAS登录号

中文名

英文名

分子结构式

分子式

详情

供应商

102516-82-5

Benzeneacetic acid, a-hydroxy-a-phenyl-,1,3-diazatricyclo[3.3.1.13,7]dec-6-yl ester;
1,3-diazatricyclo[3.3.1.13,7]decane,benzeneacetic acid deriv.

Benzo[f][4,7]phenanthroline;
1,8-diazatriphenylene

二苯并[f,h]喹诺西林

Dibenzo[f,h]quinoxaline;
1,4-diazatriphenylene;
5,6:7,8-Dibenzoquinoxaline;
NSC 74769;
Phenanthro[9,10-b]pyrazine

L-Tyrosine,N-acetyl-L-tyrosyl-L-tyrosyl-3-hydroxy-, cyclic (1®33)-ether;
2-Oxa-10,13-diazatricyclo[15.2.2.13,7]docosane,cyclic peptide deriv.;
K 13;
K 13 (enzyme inhibitor)

L-Tyrosine,3-hydroxy-O-methyl-L-tyrosyl-L-asparaginyl-, cyclic (1®3)-ether (9CI);
2-Oxa-11,14-diazatricyclo[15.2.2.13,7]docosane,cyclic peptide deriv.;
OF 4949III

L-Tyrosine,3-hydroxy-L-tyrosyl-L-asparaginyl-, cyclic (13®3)-ether (9CI);
2-Oxa-11,14-diazatricyclo[15.2.2.13,7]docosane,cyclic peptide deriv.;
OF 4949IV

Maytansine,3-O-de[2-(acetylmethylamino)-1-oxopropyl]-4,5-deepoxy-4,5-didehydro-22-demethyl-;
11-Oxa-9,19-diazatricyclo[18.3.1.18,12]pentacosane,maytansine deriv.

Maytansine,3-O-de[2-(acetylmethylamino)-1-oxopropyl]-19-dechloro-4,5-deepoxy-4,5-didehydro-;
11-Oxa-9,19-diazatricyclo[18.3.1.18,12]pentacosane,maytansine deriv.

Osmium,[3,4-diazatricyclo[3.3.0.02,6]octa-1,7-diene-7,8-diolato(2-)-kO,kO']- (9CI);
5,4,6-(Biiminometheno)-4H-cyclopent[1,2,5]osmadioxole(8CI);
Osmium, [3,4-diazatricyclo[3.3.0.02,6]octa-1,7-diene-7,8-diolato(2-)-O,O']-;
3,4-diazatricyclo[3.3.0.02,6]octa-1,7-diene-7,8-diol, osmium complex;
3,4-diazatricyclo[3.3.0.02,6]octane, osmium deriv.

Phosphoric acid,4-(5,7-dimethyl-6-oxo-1,3-diazatricyclo[3.3.1.13,7]dec-2-yl)phenyl diphenylester

Spiro[cyclohexane-1,2'-[1,3]diazatricyclo[3.3.1.13,7]decan]-6'-ol,5',7'-diphenyl-;
Spiro[cyclohexane-1,2'-[1,3]diazaadamantan]-6'-ol,5',7'-diphenyl- (8CI);
IS 3330

Spiro[cyclopentane-1,2'-[1,3]diazatricyclo[3.3.1.13,7]decan]-6'-one,5',7'-dimethyl-

Spiro[cyclohexane-1,2'-[1,3]diazatricyclo[3.3.1.13,7]decan]-6'-one,5',7'-dimethyl-

1,19-Diazoniatricyclo[32.3.1.115,19]nonatriaconta-1(38),15,17,19(39),34,36-hexaene;
1,19-diazatricyclo[32.3.1.115,19]nonatriacontane,1,19-diazoniatricyclo[32.3.1.115,19]nonatriaconta-1(38),15,17,19(39),34,36-hexaenederiv.;
Cyclostellettamine E;
MS 1620B2A1L

1,18-Diazoniatricyclo[29.3.1.114,18]hexatriaconta-1(35),14,16,18(36),31,33-hexaene;
1,18-diazatricyclo[29.3.1.114,18]hexatriacontane,1,18-diazoniatricyclo[29.3.1.114,18]hexatriaconta-1(35),14,16,18(36),31,33-hexaenederiv.;
Cyclostellettamine A;
MS 1620B2A1D

1,18-Diazoniatricyclo[31.3.1.114,18]octatriaconta-1(37),14,16,18(38),33,35-hexaene;
1,18-diazatricyclo[31.3.1.114,18]octatriacontane,1,18-diazoniatricyclo[31.3.1.114,18]octatriaconta-1(37),14,16,18(38),33,35-hexaenederiv.;
Cyclostellettamine D;
MS 1620B2A1J

1,15-diazatricyclo[26.3.1.111,15]tritriaconta-4,11,18,23,28-pentaene,(4E,18E,23Z)- (9CI);
1,15-diazatricyclo[26.3.1.111,15]tritriaconta-4,11,18,23,28-pentaene,(E,E,Z)-;
Haliclamine B